This 35-minute, on-demand session from the ASAM 2026 Review Course covers a diverse group of substances including hallucinogens, dissociatives, inhalants, and steroids as well as the physiological effects, epidemiology, and treatment options.

This 88-hour on-demand conference includes 75 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 57th Annual Conference addresses the evolving drug landscape, bridging epidemiological trends with practical clinical applications for addiction medicine practitioners.

This 35-minute, on-demand session from the ASAM 2025 Review Course covers a diverse group of substances including hallucinogens, dissociatives, inhalants, and steroids as well as the physiological effects, epidemiology, and treatment options.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course outlines recent interesting findings and topics that have emerged, from differences in formulations and routes of administration to ways research may impact the future of policy.

This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This 50-minute, on-demand session from the ASAM 2024 Review Course reviews basic concepts of epidemiology, important addiction-related epidemiological trends, and demonstrates examples of epidemiological principles and how to apply them.

This one-hour, on-demand, journal article-based activity reviews a large cross-sectional study of kratom consumers to evaluate the potential risk for dependency and addiction with kratom consumption and assess the prevalence of kratom use disorder. Up to this time, research about kratom use bas been limited and the prevalence of Kratom Use Disorder (KUD) and indivudual characteristics associated with KUD has not been well understood. The purpose of this study is to improve to gain a clearer clinical understanding of Kratom Use Disorder and better inform the medical community that interacts with patients who consume kratom about the risks of KUD development.

This one-hour, on-demand, journal article-based activity explores original qualitative research on patient perspectives regarding buprenorphine​ discontinuation in the treatment of opioid use disorder (OUD). Little is currently known about the causes of medication discontinuation from the patient perspective. ​Despite buprenorphine and other medications for OUD being the recommended standard care of treatment for OUD and the benefits of positive health and addiction-related outcomes associated with them​, half of patients discontinue medication use in the first year of treatment. Emerging in interviews with patients with OUD treated with buprenorphine were three main themes related to medication discontinuation: health system barriers, adverse effects (or apparent adverse events) associated with the medication, and patient motivations. The purpose of this activity is to better understand patient perspectives around themes of discontinuation and to explore some clinical strategies to enhance patient retention.